Sign in or Register   Sign in or Register
  |  

Mouse Anti-TMEM106B Recombinant Antibody (CBYJT-3483) (CBMAB-T2808-YJ)

Provided herein is a Mouse monoclonal antibody, which binds to TMEM106B (Transmembrane Protein 106B). The antibody can be used for immunoassay techniques, such as ELISA, IHC, WB.
See all TMEM106B antibodies

Summary

Host Animal
Mouse
Specificity
Human
Clone
CBYJT-3483
Antibody Isotype
IgG1
Application
ELISA, IHC, WB

Basic Information

Specificity
Human
Antibody Isotype
IgG1
Clonality
Monoclonal
Application Notes
The COA includes recommended starting dilutions, optimal dilutions should be determined by the end user.

Formulations & Storage [For reference only, actual COA shall prevail!]

Buffer
PBS, pH 7.4
Storage
Store at 4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Target

Full Name
TMEM106B Transmembrane Protein 106B
Introduction
TMEM106B (Transmembrane Protein 106B) is involved in dendrite morphogenesis and maintenance by regulating lysosomal trafficking via its interaction with MAP6. It may act by inhibiting retrograde transport of lysosomes along dendrites. It is required for dendrite branching.
Entrez Gene ID
54664
UniProt ID
Q9NUM4
Alternative Names
Transmembrane Protein 106B
Function
In neurons, involved in the transport of late endosomes/lysosomes (PubMed:25066864).
May be involved in dendrite morphogenesis and maintenance by regulating lysosomal trafficking (PubMed:25066864).
May act as a molecular brake for retrograde transport of late endosomes/lysosomes, possibly via its interaction with MAP6 (By similarity).
In motoneurons, may mediate the axonal transport of lysosomes and axonal sorting at the initial segment (By similarity).
It remains unclear whether TMEM106B affects the transport of moving lysosomes in the anterograde or retrograde direction in neurites and whether it is important in the sorting of lysosomes in axons or in dendrites (By similarity).
In neurons, may also play a role in the regulation of lysosomal size and responsiveness to stress (PubMed:25066864).
Required for proper lysosomal acidification (By similarity).
(Microbial infection) May act as a proviral host factor for SARS-CoV-2, but not for common cold coronaviruses HCoV-229E and HCoV-OC43.
Biological Process
Biological Process dendrite morphogenesisSource:UniProtKB1 Publication
Biological Process lysosomal lumen acidificationSource:Ensembl
Biological Process lysosomal protein catabolic processSource:Ensembl
Biological Process lysosomal transportSource:GO_Central1 Publication
Biological Process lysosome localizationSource:UniProtKB1 Publication
Biological Process lysosome organizationSource:GO_Central1 Publication
Biological Process neuron cellular homeostasisSource:Ensembl
Biological Process positive regulation of dendrite developmentSource:Ensembl
Biological Process positive regulation of hydrolase activitySource:Ensembl
Biological Process regulation of lysosome organizationSource:Ensembl
Cellular Location
Late endosome membrane
Lysosome membrane
Colocalizes with LAMP1.
Involvement in disease
Ubiquitin-positive frontotemporal dementia (UP-FTD):
Frontotemporal dementia (FTD) is the second most common cause of dementia in people under the age of 65 years. It is an autosomal dominant neurodegenerative disease.
Frontotemporal dementia and/or amyotrophic lateral sclerosis 1 (FTDALS1):
An autosomal dominant neurodegenerative disorder characterized by adult onset of frontotemporal dementia and/or amyotrophic lateral sclerosis in an affected individual. There is high intrafamilial variation. Frontotemporal dementia is characterized by frontal and temporal lobe atrophy associated with neuronal loss, gliosis, and dementia. Patients exhibit progressive changes in social, behavioral, and/or language function. Amyotrophic lateral sclerosis is characterized by the death of motor neurons in the brain, brainstem, and spinal cord, resulting in fatal paralysis.
Leukodystrophy, hypomyelinating, 16 (HLD16):
An autosomal dominant disorder characterized by hypomyelination, leukodystrophy, and thin corpus callosum observed on brain imaging. Clinical features include hypotonia, nystagmus, and mildly delayed motor development with onset in infancy, ataxic or broad-based gait, hyperreflexia, intention tremor, dysmetria, and a mild pyramidal syndrome. Some patients have cognitive impairment, whereas others may have normal cognition or mild intellectual disability with speech difficulties.
Topology
Cytoplasmic: 2-96
Helical: 97-117
Lumenal: 118-274
Ask a question We look forward to hearing from you.
0 reviews or Q&As

Purchasing FAQs
Technical FAQs

Loading...
Have you used Mouse Anti-TMEM106B Recombinant Antibody (CBYJT-3483)?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon $30 eGift Card
Submit a review
Loading...
For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Online Inquiry

Documents

Contact us

  • Tel: (USA)
  • (UK)
  • Fax:
  • Email:

Submit A Review

Go to
Compare